with Steven M. Paul, David A. Lewis, Cornelia Bargmann and more on Aug 17, 2012
with Steven M. Paul, David A. Lewis, Cornelia Bargmann and more on Mar 30, 2012
Dr. Paul is currently the Director of the Appel Alzheimer’s Disease Research Institute and a Professor of Neurology (Neuroscience) and Psychiatry at Weill Cornell Medical College of Cornell University. He has more than 17 years of management experience in the pharmaceutical industry and 35 years of scientific research experience. He retired effective March 1, 2010 as Executive Vice President for Science and Technology and President of the Lilly Research Laboratories of Eli Lilly and Company (Lilly), a pharmaceutical company that engages in the discovery, development, manufacturer and sale of pharmaceutical products, positions he held since 2003. He joined Lilly in April 1993 and served in roles of increasing responsibility within the Lilly research organization, including Vice President of Discovery Research and Clinical Investigation. Prior to joining Lilly, Dr. Paul served in several senior roles at the National Institute of Mental Health, including serving as the Scientific Director of the Intramural Research Program. Dr. Paul has authored or coauthored more than 500 papers and invited book chapters and serves on the editorial boards of numerous scientific journals and as a grant reviewer for several extramural and intramural committees. He has been a director of the Company since November 2006. He is a director of Alnylam Pharmaceuticals and a Venture Partner at Third Rock Ventures. He is also a director of the Foundation of the National Institutes of Health, a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Association for the Advancement of Science.
Source - http://people.forbes.com/profile/steven-m-paul/28913
